PASITHEA THERAPEUTICS CORP's ticker is and the CUSIP is 70261F103. A total of 13 filers reported holding PASITHEA THERAPEUTICS CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,995 | -2.0% | 12,490 | +0.0% | 0.00% | – |
| Q2 2023 | $6,120 | +122300.0% | 12,489 | -0.9% | 0.00% | – |
| Q1 2023 | $5 | -50.0% | 12,601 | -16.3% | 0.00% | – |
| Q4 2022 | $10 | -99.9% | 15,049 | +165.9% | 0.00% | – |
| Q3 2022 | $7,000 | +250.0% | 5,659 | +151.1% | 0.00% | – |
| Q2 2022 | $2,000 | -96.2% | 2,254 | -92.3% | 0.00% | -100.0% |
| Q4 2021 | $52,000 | +766.7% | 29,385 | +1502.2% | 0.00% | – |
| Q3 2021 | $6,000 | – | 1,834 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| K2 PRINCIPAL FUND, L.P. | 550,000 | $715,000 | 0.06% |
| MARK SHEPTOFF FINANCIAL PLANNING, LLC | 48,000 | $62,000 | 0.03% |
| TWO SIGMA SECURITIES, LLC | 18,899 | $25,000 | 0.00% |
| VANGUARD GROUP INC | 56,583 | $74,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 84 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| BlackRock Inc. | 9,962 | $13,000 | 0.00% |
| Citadel Advisors | 72,937 | $95,000 | 0.00% |
| JPMORGAN CHASE & CO | 1,000 | $1,000 | 0.00% |